article thumbnail

Cannabinoids for Tinnitus?

Project CBD

5 As far as human studies, the review authors also summarize two previous surveys in 2010 and 2019, a 1975 clinical trial and a 2006 case study — whose cumulative findings are, at best, entirely unclear. While the collective evidence to date is mixed and inconclusive, it’s also incomplete.

article thumbnail

A Patient’s Guide to CBD and Drug Interactions

Healer

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Epilepsy & behavior case reports 9 (2018): 10. 2006): 349-353. Alsherbiny, Muhammad, and Chun Li. Medicinal Cannabis—Potential Drug Interactions.” Medicines 6.1

CBD 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Using Cannabis for ALS: Benefits, Research and Best Strains

Greencamp

The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). The first study I will reference is from 2006, conducted on mice.

Strains 94
article thumbnail

A Patient’s Guide to CBD and Drug Interactions

Healer

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Epilepsy & behavior case reports 9 (2018): 10. [4] 2006): 349-353. Drug metabolism reviews 46.1 2014): 86-95. [2] 2] Alsherbiny, Muhammad, and Chun Li.

CBD 52
article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Lancet Neurol Dec 23 2015. Fabricio A.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Conclusions. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).